Related Experiment Videos
Upper gastrointestinal bleeding: what has changed during the last 20 years?
J Henrion1, M Schapira, J-M Ghilain
1Service d'hépatogastroentérologie, hôpital de Jolimont, rue Ferrer, Haine-Saint-Paul, Belgium. jeanhenrion@yahoo.fr
Gastroenterologie Clinique Et Biologique
|September 13, 2008
Summary
Upper gastrointestinal bleeding (UGIB) management has evolved significantly over two decades. While etiologies shifted and treatments improved, patient outcomes like mortality remain unchanged, highlighting areas for future focus in UGIB care.
Area of Science:
- Gastroenterology
- Internal Medicine
- Clinical Research
Background:
- Upper gastrointestinal bleeding (UGIB) represents a significant clinical challenge.
- Understanding trends in UGIB is crucial for optimizing patient care and resource allocation.
Purpose of the Study:
- To evaluate changes in clinical presentation, epidemiology, treatment, and prognosis of UGIB patients over a 20-year period.
- To compare patient cohorts from two distinct time periods to identify significant shifts in UGIB management and outcomes.
Main Methods:
- A comparative study design was employed, analyzing two cohorts of 200 patients each.
- Cohort A comprised patients from 1984-1987, while Cohort B included patients from 2004-2006.
- Data on demographics, etiology, treatment interventions, and outcomes were collected and analyzed.
Main Results:
- The patient population aged, with esophagitis and Mallory-Weiss syndrome becoming more frequent causes of UGIB.
- Therapeutic endoscopy interventions increased significantly (36% vs 2%), and blood transfusions decreased.
- While surgery rates and rebleeding decreased by half, overall mortality remained stable.
Conclusions:
- Significant epidemiological, therapeutic, and prognostic shifts have occurred in UGIB management over the past two decades.
- Improvements in endoscopic interventions have reduced the need for surgery and recurrent bleeding.
- Despite advances, mortality rates for UGIB necessitate continued research and improved therapeutic strategies.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:24Esophageal Varices-I: Introduction
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:30Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...